Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 11:07 am Sale | 2023-09-29 | 13G | Intercept Pharmaceuticals, Inc. ICPT | The Vanguard Group | 2,071,222 4.950% | -2,622,585 (-55.87%) | Filing History |
| 2023-07-10 10:41 am Purchase | 2023-06-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT | The Vanguard Group | 4,693,807 11.260% | 1,055,872 (+29.02%) | Filing History |
| 2023-07-07 4:35 pm Purchase | 2023-06-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 4,396,970 10.500% | 1,312,137 (+42.54%) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Point72 Asset Management, L.P. | 392,151 0.900% | -1,968,718 (-83.39%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT | The Vanguard Group | 3,637,935 8.780% | 1,666,176 (+84.50%) | Filing History |
| 2023-02-02 12:24 pm Sale | 2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | STATE STREET CORP STT | 3,175,925 7.670% | -78,341 (-2.41%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 3,084,833 7.400% | 852,741 (+38.20%) | Filing History |
| 2023-01-13 4:17 pm Sale | 2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Millennium Management LLC | 976,706 2.400% | -547,610 (-35.92%) | Filing History |
| 2022-10-11 8:29 pm Purchase | 2022-10-03 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Point72 Asset Management, L.P. | 2,360,869 5.700% | 2,360,869 (New Position) | Filing History |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Intercept Pharmaceuticals, Inc. ICPT | FMR LLC | 934,378 2.371% | -1,705,055 (-64.60%) | Filing History |
| 2022-09-02 4:58 pm Sale | 2022-09-02 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Genextra S.p.A. | 4,000,000 13.400% | -31,994 (-0.79%) | Filing History |
| 2022-08-18 4:13 pm Purchase | 2022-08-12 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Millennium Management LLC | 1,524,316 5.100% | 1,524,316 (New Position) | Filing History |
| 2022-02-11 08:16 am Purchase | 2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | STATE STREET CORP STT | 3,254,266 11.010% | 23,796 (+0.74%) | Filing History |
| 2022-02-10 08:17 am Sale | 2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | The Vanguard Group | 1,971,759 6.670% | -1,391,318 (-41.37%) | Filing History |
| 2022-02-09 09:19 am Sale | 2022-02-08 | 13G | Intercept Pharmaceuticals, Inc. ICPT | FMR LLC | 2,639,433 8.884% | -1,087,481 (-29.18%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | BlackRock Inc. BLK | 2,232,092 7.600% | -266,316 (-10.66%) | Filing History |
| 2022-02-02 09:41 am Sale | 2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | First Trust Portfolios L.P. | 0 0.000% | -1,975,601 (Position Closed) | Filing History |
| 2021-12-10 09:28 am Purchase | 2021-11-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT | STATE STREET CORP STT | 3,230,470 10.930% | 679,720 (+26.65%) | Filing History |
| 2021-06-10 10:06 am Purchase | 2021-05-28 | 13G | Intercept Pharmaceuticals, Inc. ICPT | The Vanguard Group | 3,363,077 10.140% | 534,122 (+18.88%) | Filing History |
| 2021-02-11 1:10 pm Purchase | 2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | STATE STREET CORP STT | 2,550,750 7.730% | 2,550,750 (New Position) | Filing History |